MCM
GMAB icon

MV Capital Management’s Genmab GMAB Stock Holding History

MV Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165 Sell
6
-31
-84% -$824 ﹤0.01% 1169
2026
Q1 		$993 Buy
37
+27
+270% +$809 ﹤0.01% 868
2025
Q4 		$308 Buy
+10
New +$312 ﹤0.01% 981

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

MV Capital Management's GMAB Position: Q2 2026 in Review

MV Capital Management reduced its Genmab (GMAB) stake by 84% in Q2 2026, selling an estimated $824 and leaving 6 shares worth $165. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

MV Capital Management first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $993 in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • MV Capital Management held 6 shares of Genmab worth $165 as of Q2 2026.
  • MV Capital Management sold 31 Genmab shares in Q2 2026, an estimated $824.
  • Genmab made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #1169 holding.
  • MV Capital Management first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • MV Capital Management's Genmab position peaked at $993 in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.